600062.SS SHH
China Resources Double-Crane Pharmaceutical Co.,Ltd.
1W: +0.9%
1M: +1.0%
3M: -3.0%
YTD: -13.3%
1Y: -19.1%
3Y: +1.2%
5Y: +58.6%
¥16.24 ($2.42)
+0.32 (+2.01%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$17.0B
+1.9% ▲
5Y CAGR: +6.5%
Total Liabilities
$4.5B
-19.1% ▼
5Y CAGR: +8.2%
Shareholders Equity
$11.6B
+11.8% ▲
5Y CAGR: +4.6%
Cash & Investments
$2.4B
-15.3% ▼
5Y CAGR: -5.8%
Total Debt
$1.2B
-1.6% ▼
5Y CAGR: +180.7%
Net Debt
-$758M
+54.8% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $2.8B | $2.6B | $3.5B | $2.9B | $1.9B |
| Short-Term Investments | $804M | $200M | -$5M | $0 | $501M |
| Cash & ST Investments | $3.6B | $2.8B | $3.5B | $2.9B | $2.4B |
| Net Receivables | $2.0B | $2.6B | $2.4B | $2.8B | $2.9B |
| Inventory | $1.7B | $1.9B | $1.6B | $1.6B | $1.6B |
| Other Current Assets | $241M | $697M | $270M | $99M | $133M |
| Total Current Assets | $7.5B | $7.2B | $7.6B | $7.5B | $7.1B |
| Property, Plant & Equip. | $3.0B | $3.5B | $3.8B | $4.2B | $4.4B |
| Goodwill & Intangibles | $2.7B | $3.2B | $3.4B | $3.4B | $3.6B |
| Long-Term Investments | -$500M | $150M | $357M | $1.0B | $1.3B |
| Other Non-Current Assets | $935M | $321M | $111M | $435M | $379M |
| Total Non-Current Assets | $6.2B | $7.3B | $7.8B | $9.2B | $9.9B |
| Total Assets | $13.7B | $14.5B | $15.4B | $16.7B | $17.0B |
| — Liabilities — | |||||
| Accounts Payable | $847M | $731M | $740M | $836M | $669M |
| Short-Term Debt | $5M | $5M | $30M | $64M | $106M |
| Deferred Revenue | $1.8B | $193M | $0 | $0 | $0 |
| Other Current Liabilities | $1.7B | $1.9B | $2.0B | $220M | $250M |
| Total Current Liabilities | $2.7B | $3.0B | $3.2B | $4.0B | $3.0B |
| Long-Term Debt | $0 | $200M | $0 | $1.1B | $1.0B |
| Other Non-Current Liab. | $159M | $149M | $292M | $175M | $168M |
| Total Non-Current Liabilities | $469M | $741M | $479M | $1.6B | $1.5B |
| Total Liabilities | $3.2B | $3.8B | $3.6B | $5.6B | $4.5B |
| — Equity — | |||||
| Common Stock | $1.0B | $1.0B | $1.0B | $1.0B | $1.0B |
| Retained Earnings | $8.2B | $8.6B | $10.0B | $9.2B | $10.4B |
| Accumulated OCI | $562M | $594M | $380M | -$19M | $231M |
| Total Stockholders Equity | $9.9B | $10.0B | $11.1B | $10.4B | $11.6B |
| Total Liabilities & Equity | $13.7B | $14.5B | $15.4B | $16.7B | $17.0B |
| — Key Metrics — | |||||
| Total Debt | $65M | $265M | $60M | $1.2B | $1.2B |
| Net Debt | -$2.8B | -$2.4B | -$3.4B | -$1.7B | -$758M |
| Total Investments | $303M | $350M | $357M | $1.0B | $1.8B |